Activating the Potential of Gamma Delta T-Cells in Preclinical Models: A Next-Generation Strategy to Minimize CRS & Rethink TCE Safety in Autoimmunity
Time: 1:00 pm
day: Day Two
Details:
- How to selectively target powerful but rare cell-types such as gamma-delta T cells for target cell elimination, alternatives to CD3
- Solving the scarcity issue: How to unlock the power of gamma delta T-cell engagers through novel design or mechanism to expand and activate gamma-delta T cells.
- Discussion of the shifting paradigm as we move from Oncology to Autoimmune indications in T cell engagers, can we realize the potential of safe and deep immune reset
